Exelixis (EXEL)
(Delayed Data from NSDQ)
$26.97 USD
-0.20 (-0.74%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $26.97 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 29% (72 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.55 | 1.35 | 9.99 |
Current Quarter Estimate | 0.41 | 7.43 | 61.00 |
Year Ago Quarter Estimate | 0.10 | 0.12 | 54.84 |
Next Quarter Estimate | 0.41 | 7.81 | 63.00 |
Next Year Estimate | 1.79 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 63.33 | 16.80 | 15.67 |
Next Year | 21.77 | 9.90 | 11.34 |
Last 5 Years | -8.10 | 0.70 | 8.10 |
Next 5 Years | 34.10 | 21.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 18.73 | -2.18 |
Price/Book (MRQ) | 3.63 | 2.03 |
Price/Cash Flow (MRFY) | 35.02 | 16.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.38% | -22.37% |
Return on Equity (TTM) | 15.54% | -31.10% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.